Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases

According to a story from UPI, gene editing technology could be a potential treatment for mitochondrial diseases, a rare, genetic illness that is usually fatal. In a proof-of-concept experiment, researchers…

Continue Reading Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases
Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Free-Photos / Pixabay

Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials

According to a story from Angioedema News, an investigational product from BioCryst Pharmaceuticals called BCX7353 was able to quickly subdue swelling attacks in hereditary angioedema in clinical trials. In addition,…

Continue Reading Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation
PDPics / Pixabay

Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation

According to a story from globenewswire.com, the pharmaceutical company Portola Pharmaceuticals recently announced that its investigational product cerdulatinib has earned Orphan Drug designation from the US Food and Drug Administration…

Continue Reading Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation

A Boy With Congenital Muscular Dystrophy is Being Supported in a Special Way

Michael Dickerson, aged 42, is originally from Hoedspruit Limpopo, South Africa. Recently, Michael was participating in a series of long distance trail runs when he learned about the story of Daniël…

Continue Reading A Boy With Congenital Muscular Dystrophy is Being Supported in a Special Way
ICYMI: After Rejection, The Familial Chylomicronemia Foundation Urges The FDA to Consider Approving New Treatment
www_slon_pics / Pixabay

ICYMI: After Rejection, The Familial Chylomicronemia Foundation Urges The FDA to Consider Approving New Treatment

According to a story from BioSpace, the U.S. Food and Drug Administration (FDA) recently rejected the approval of the drug Waylivra, which was in development for the treatment of familial…

Continue Reading ICYMI: After Rejection, The Familial Chylomicronemia Foundation Urges The FDA to Consider Approving New Treatment
Misha Walker Advocates For Arthrogryposis Patients One State at a Time
https://pixabay.com/en/morning-sunrise-woman-silhouette-2243465/

Misha Walker Advocates For Arthrogryposis Patients One State at a Time

  Misha Walker and her husband Mike have spent the summer in England, meeting with families who have children with a rare condition called arthrogryposis multiplex congenita (AMC). In the…

Continue Reading Misha Walker Advocates For Arthrogryposis Patients One State at a Time
Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs
rawpixel / Pixabay

Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs

According to a story from Research & Development, increasing collaboration between a variety of different organizations is helping to propel and improve the develop of new drugs for the treatment…

Continue Reading Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs

A Gene Therapy for Wet Age-Related Macular Degeneration has Progressed to Clinical Trials

The United States Food and Drug Administration has awarded Fast Track Designation to an experimental gene therapy for the treatment of wet age-related macular degeneration. For more detailed information, you…

Continue Reading A Gene Therapy for Wet Age-Related Macular Degeneration has Progressed to Clinical Trials
Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine
geralt / Pixabay

Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine

According to a story from blogs.bmj.com, the situation has been tense recently in the halls of the Cochrane Collaboration. Cochrane is a non-profit organization that involves the work of over…

Continue Reading Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine

Experimental Treatment For Small Cell Lung Cancer Receives Orphan Drug Designation

According to a story from pm360online.com, the drug development company Cytori Therapeutics recently announced that its investigational product ATI-1123 has been granted Orphan Drug designation from the US Food and…

Continue Reading Experimental Treatment For Small Cell Lung Cancer Receives Orphan Drug Designation